The Checklist Top ASCs Use to Prevent 86% of Claim Denials

Walk into almost any revenue cycle organization and you will find the same picture. A denials team, often the most experienced billers in the building, spends the bulk of its week on claims that already came back. They read the remittance, decode the reason, rebuild the documentation, resubmit, and wait. Then they do it again. The work is skilled, it is relentless, and it is aimed almost entirely at the past. This is the quiet reality of denial management in 2026: it has become one of the largest and most expensive functions in the revenue cycle, and most of the effort inside it is spent cleaning up claims that never should have gone out the way they did.

The pressure is getting worse, not better. Initial denial rates now sit near 12%, and the trend line is pointing up. In Experian Health's 2025 State of Claims survey, 41 percent of providers reported denial rates above 10 percent, up from 38 percent in 2024 and 30 percent in 2022. More than half say claim errors are increasing, and 68 percent say submitting a clean claim is harder than it was a year ago. The dollars behind each denial are climbing too. A 2025 analysis of more than 1.2 million providers found the average denied inpatient claim rose 12 percent and outpatient 14 percent year over year, with denials tied to a request for information or medical necessity jumping 70 percent to an average of 450 dollars.

The economics of reworking a denial are already a loss

The instinct when denials rise is to add capacity to the denials team. The math on that instinct is unforgiving. The average cost to rework a single claim is about $25, and complex claims run far higher. That cost is pure margin erosion, because reworking a claim recovers money you had already earned and were simply denied. You are paying twice to collect once.

It gets worse. As many as two-thirds of denied claims are never reworked at all. They are written off, quietly, because the team ran out of hours before it ran out of denials. Every one of those write-offs is revenue the group performed the work to earn and then abandoned at the finish line. And the part that should reframe the entire conversation is this: 86% of denials are potentially avoidable. The denials team is not fighting an unavoidable cost of doing business. It is absorbing the downstream consequences of decisions made much earlier in the workflow.

Most denials are decided before the claim is ever coded

Look at where denials actually originate and the picture sharpens. Roughly half of all denials trace to front-end issues, before a coder ever touches the chart. Registration and eligibility problems are the single largest category at 27 percent. Authorization and pre-certification failures account for another 11.6 percent. Service-not-covered adds more. These are not coding mistakes or clinical judgment calls. They are questions with knowable answers at the time of scheduling: is this patient's coverage active, does this payer require authorization for this procedure, does the documentation on file satisfy this payer's medical necessity criteria, do the CPT and ICD-10 codes align with what this payer will accept.

The denials team sees the answer to every one of those questions weeks later, written on a remittance, when the only path forward is an appeal. The information needed to prevent the denial existed before the patient walked in. The workflow simply never checked for it at the point where checking was cheap.

What the groups pulling ahead do differently

The best-performing revenue cycle organizations have stopped treating denial management as a back-end recovery function and started treating it as a front-end prevention problem. The shift is less about buying a denials tool and more about moving the entire question upstream, to the moment before a claim is submitted, when a fix costs a few minutes instead of a few weeks. In practice, that shift shows up as a handful of specific capabilities working before submission rather than after.

The first is real-time eligibility and coverage verification at registration and again before the claim goes out. Instead of learning about a coverage lapse from a denial, the system flags it while there is still time to correct the plan on file or reach the patient, hours or days before the payer ever renders a decision.

The second is pre-submission denial scoring. Predictive models trained on a group's own denial history and payer behavior read a claim before it leaves and estimate how likely each payer is to deny it. A claim that scores high for denial risk gets held and routed to a human before submission, not after a remittance comes back. This is the operational core of the move from reactive to predictive. The work does not disappear, it moves thirty days earlier, to a point where correcting it is cheap and recovery is not yet at risk.

The third is payer-specific edits applied automatically at the claim level. Bundling and NCCI rules, frequency limits, site-of-service requirements, and local and national coverage criteria change constantly and vary by payer. A rules layer that checks each claim against the current version of those requirements catches the mismatch that a busy biller working across five specialties and a dozen payers cannot reasonably hold in their head.

The fourth is prior authorization handled as a workflow rather than a fire drill. Systems that determine per-payer and per-procedure whether authorization is required, initiate the request, and track its status and expiration remove the single largest source of denials on elective and procedural work. A denial after a procedure is recoverable through appeals. An authorization that never cleared before the procedure date usually is not.

The fifth is documentation-gap detection that reads the clinical record against the requirements for the specific claim and surfaces what is missing while the encounter is still fresh, so the medical necessity question is answered before the claim is built rather than litigated after it is denied.

None of these replace the denials team. They change what the denials team spends its time on. When the front end catches the avoidable 86 percent, the experienced billers are freed to work the genuinely complex, genuinely contestable denials, the ones where their judgment and their relationships with payers actually move dollars. The handoff to a human happens on the exceptions, after the automated layer has cleared everything it can clear.

The adoption gap is the opportunity

Here is the number that should sit uncomfortably with any RCM leader. Despite denials rising for four straight years, only 14 percent of providers currently use AI to reduce them. Among the groups that do, 69 percent report that it has reduced denials, improved resubmission success, or both. The tools work, and the field has barely adopted them. At the same time, only 56 percent of providers believe their current technology can handle the demands of the revenue cycle, down sharply from 77 percent in 2022. The confidence in the old way is eroding faster than the investment in the new one is arriving.

That gap is where the competitive separation is happening right now. The groups that move first are compounding a structural advantage: fewer denials to work, so a smaller and more senior denials team, so lower cost to collect, so more margin to reinvest. The groups that wait are adding headcount to a function whose economics only get worse as denial rates and denied dollar amounts keep climbing.

What this means for the next twelve months

The direction is clear enough to plan around. Denial management is moving from a recovery discipline to a prevention discipline, and the center of gravity is moving from the back end of the revenue cycle to the front. The organizations that succeed will be the ones that treat every denial not as a claim to rework but as a signal about a decision made upstream, and that build the loop to close that gap before the next claim goes out. The economics of reworking denials were never good. What has changed is that the tools to prevent them are now real, proven, and adopted by a small enough share of the market that early movers still get to be early.

Exactrx builds the prevention layer for exactly this: scoring claims for denial risk before submission, checking each one against current payer rules and coverage criteria, and surfacing the eligibility, authorization, and documentation gaps that drive the avoidable majority of denials. If you are a revenue cycle leader who wants to compare notes on what your denial data is telling you and where the preventable dollars are hiding, the line is open at partnerships@exactrx.ai.